WallStSmart

Compass Inc (COMP)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 42% more annual revenue ($11.77B vs $8.31B). WELL leads profitability with a 12.0% profit margin vs 0.2%. WELL trades at a lower P/E of 103.3x. WELL earns a higher WallStSmart Score of 57/100 (C).

COMP

Buy

56

out of 100

Grade: C

Growth: 8.0Profit: 3.0Value: 3.0Quality: 4.5
Piotroski: 2/9Altman Z: 2.52

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 7.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COMPSignificantly Overvalued (-81.8%)

Margin of Safety

-81.8%

Fair Value

$6.16

Current Price

$7.71

$1.55 premium

UndervaluedFair: $6.16Overvalued
WELLSignificantly Overvalued (-84.0%)

Margin of Safety

-84.0%

Fair Value

$116.05

Current Price

$200.84

$84.79 premium

UndervaluedFair: $116.05Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COMP3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
99.4%10/10

Revenue surging 99.4% year-over-year

EPS GrowthGrowth
75.0%10/10

Earnings expanding 75.0% YoY

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$150.23B9/10

Large-cap with strong market position

Areas to Watch

COMP4 concerns · Avg: 3.0/10
Return on EquityProfitability
0.5%3/10

ROE of 0.5% — below average capital efficiency

Profit MarginProfitability
0.2%3/10

0.2% margin — thin

Debt/EquityHealth
1.393/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
103.3x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : COMP

The strongest argument for COMP centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 99.4% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : COMP

The primary concerns for COMP are Return on Equity, Profit Margin, Debt/Equity. A P/E of 429.5x leaves little room for execution misses. Thin 0.2% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 103.3x leaves little room for execution misses.

Key Dynamics to Monitor

COMP profiles as a hypergrowth stock while WELL is a growth play — different risk/reward profiles.

COMP carries more volatility with a beta of 2.44 — expect wider price swings.

COMP is growing revenue faster at 99.4% — sustainability is the question.

WELL generates stronger free cash flow (282M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 56/100) and 38.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Compass Inc

REAL ESTATE · REAL ESTATE SERVICES · USA

Urban Compass, Inc., which is Compass, is a real estate brokerage company. The company is headquartered in New York, New York.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?